USOSM: The Oral Surgery MSO Built on Surgeon Equity

Most dental consolidators are generalists that fold a few specialty practices into a much larger general-dentistry network. U.S. Oral Surgery Management (USOSM) did the opposite. From its 2017 founding it bet on a single, high-acuity specialty — oral and maxillofacial surgery — and built the first national platform dedicated to it alone. The more unusual bet is on the cap table: USOSM reports that the oral surgeons themselves own more than half the company. For an investor studying where dental consolidation goes after the general-dentistry land grab, USOSM is the cleanest case study in specialty roll-ups and surgeon-aligned equity that the sector offers.

This profile is an independent assessment drawn from USOSM's own disclosures, its private-equity sponsors' transaction announcements, and reputable industry press. Where a figure comes directly from the company we say so; where counts vary by reporting date, or where a number cannot be confirmed, we flag the hedge.

Overview

USOSM is a specialty management services organization (MSO) headquartered in Irving, Texas, that exclusively serves board-certified oral and maxillofacial surgeons. The company describes itself as "the first and largest physician practice management (PPM) company focused exclusively on the oral and maxillofacial surgery specialty" — a positioning it has held since founding and that the available evidence supports.¹

The business is a classic MSO/PPM structure: USOSM does not practice surgery. It manages the non-clinical side of partner practices — operations, marketing, revenue-cycle management, IT, finance, HR, legal, compliance, managed-care contracting, volume purchasing, and recruitment — while the surgeons retain clinical autonomy and continue to own the professional entities that deliver care.¹ That separation is how the model stays compliant with the corporate-practice-of-medicine and -dentistry doctrines that, in many states, bar non-clinicians from owning or directing a clinical practice.

Oral and maxillofacial surgery sits at the intersection of dentistry and medicine — extractions and dental implants at one end, orthognathic (jaw) surgery, facial trauma, and pathology at the other. Those practices look more like surgical physician groups than routine dental offices, carrying anesthesia, surgical suites, advanced imaging, and higher-reimbursement case mixes — which is why USOSM calls itself a PPM rather than a dental support organization, even though structurally it shares much of the DSO playbook.

Company Snapshot

• Founded: November 2017, by private-equity sponsors RiverGlade Capital and the Thurston Group, through the combination of two large Texas oral surgery groups.²
• Headquarters: Irving, Texas (its "practice support center").¹
• Model: Single-specialty MSO/PPM for oral and maxillofacial surgeons — non-clinical business support to surgeon-owned partner practices, with surgeon equity rollover.
• Footprint: Approximately 30 states, with more than 250 affiliated oral and maxillofacial surgeons (company-reported; counts vary by date — see Footprint Analysis).³
• Surgeon ownership: More than 54% of the company is reported to be owned by the oral surgeons themselves.¹
• Partner retention: A reported 100% partner-practice retention rate (company-reported, as of late 2024).¹
• Current owner of record: Oak Hill Capital, a North America middle-market private-equity firm, which acquired the controlling stake from RiverGlade in a November 2021 recapitalization; management and surgeon partners retained significant equity.²
• Leadership: Doug Drew, CEO (effective July 1, 2025); founding CEO Richard "Rick" Hall transitioned to Chairman of the Board.⁴
• Revenue: Not company-disclosed; we do not publish an estimate (see Business Model).

Footprint Analysis

USOSM's scale is best read as a moving band rather than a fixed number, because the network adds partners continually and counts itself in several different units. The distinction matters for diligence, so it is worth being precise about the terms.

A practice is a distinct surgeon-owned entity, often multi-surgeon, operating under its own local brand; a clinic, location, or office is an individual site where patients are seen (one practice can run several); a surgeon is an individual board-certified OMS affiliated with a partner practice. These should never be added together or used interchangeably.

The clearest fixed snapshot comes from RiverGlade's November 2021 sale announcement, which described USOSM as "48 oral surgery practices and 141 surgeons serving patients at 124 clinics across 18 states."² That single sentence captures all four units at once and shows the relationship between them — roughly 2.6 clinics per practice, on the order of three surgeons per practice — making it the most reliable structural anchor in USOSM's public record.

From there, the company's own milestones trace a rapid climb, reported mostly in surgeons and states. By late 2022, USOSM described more than 160 practice locations across 24 states.³ By the time it entered Maryland it reported more than 230 surgeons across 27 states, and by December 2024 it reported more than 250 oral and maxillofacial surgeons in 28 states.¹ Its most recent self-description, in mid-2025, places the network at roughly 30 states.⁴ The defensible reading is that USOSM today spans approximately 30 states with more than 250 affiliated surgeons — company-reported snapshots that are likely modestly higher than the last hard count, given the platform's acquisition tempo.⁴

What the public record does not provide is a current, definitive practice or location count. USOSM has not restated those figures since the 2021/2022 anchors, and applying the old clinics-per-practice ratio to today's surgeon count would be an inference, not a confirmed number. The honest characterization: at least 160 locations as of late 2022 with continued additions since, but no company-confirmed current total. Geographically the network is genuinely national — from Texas, Colorado, Georgia, and Florida to Arizona, California, the Pacific Northwest, Massachusetts, and Michigan — rather than concentrated in one region.³

Growth History

USOSM grew the familiar private-equity way — anchor acquisitions, then buy-and-build — but under an unusually clean two-sponsor lineage that an investor should study closely.

The platform was formed in November 2017 by RiverGlade Capital, a healthcare-focused private-equity firm, in partnership with the Chicago-based Thurston Group. Rather than starting from a single office, the sponsors assembled scale on day one by combining two established Texas groups: Austin Oral Surgery (13 board-certified surgeons across 12 Central Texas locations) and Oral Surgery Associates of North Texas, or OSANT (five surgeons across five Dallas-area locations).² That gave USOSM an immediate multi-surgeon, multi-site base and a template — partner with large, reputable groups — that it repeated as it scaled.

The ownership chain, per the sponsors' own announcements, runs:

• RiverGlade Capital and the Thurston Group (2017): founding co-sponsors. RiverGlade was the lead, describing itself as having "scaled the company from its foundation" to an industry-leading provider, and Thurston the co-sponsor.²
• Oak Hill Capital (November 2021): acquired RiverGlade's controlling stake in a recapitalization. Thurston exited entirely at the same time, while the management team and surgeon partners retained significant ownership.² Oak Hill is a New York middle-market firm with more than $17 billion of initial capital commitments and co-investments since inception.²

A point worth flagging for diligence: the current sponsor's entry is 2021, not 2018 or 2019, and the deal was a recapitalization in which RiverGlade sold control and Thurston exited — not a clean single-buyer takeout. Terms were not disclosed, so the precise valuation and equity split cannot be confirmed. Company communications through the December 2024 financing continue to name Oak Hill as USOSM's backer, with no public evidence of any change of control since 2021.¹

Under Oak Hill, the platform layered on debt capacity to fund acquisitions: a reported $125 million credit facility in 2022, an additional $150 million in 2023, and a $175 million expansion in December 2024, described as an upsize of the existing facility to fund growth through 2026.¹ The most recent governance milestone is a leadership transition: effective July 1, 2025, Doug Drew became CEO and founding CEO Rick Hall moved to Chairman. Drew arrived from outside dentistry — he had been Global President of Mars Veterinary Health (the world's largest veterinary platform) and held executive roles at the publicly traded veterinary consolidator VCA — a profile that signals continued focus on scaling a multi-site, doctor-led healthcare platform.⁴

Business Model

USOSM earns its return the way MSOs do: it provides business and management services to surgeon-owned practices for a performance-tied management fee, capturing a share of the efficiency it creates. It does not bill patients for clinical care — the surgeon-owned practices do — so its economics flow from those support relationships and the scale they unlock.²

The service suite is comprehensive: the company centralizes operations, marketing, revenue-cycle management, IT, finance, human resources, legal, compliance, managed-care contracting, volume purchasing, and recruitment.¹ The pitch to surgeons is that they offload the parts of running a business that surgical training never covered — payer negotiation, billing, compliance, recruiting — while keeping clinical control and their local brand.

Two features distinguish the model from a typical general DSO. The first is the single-specialty focus: by serving only oral and maxillofacial surgeons, USOSM can tailor its operational playbook, payer contracting, and referral management to OMS economics rather than spreading across general dentistry. The second, and more striking, is the surgeon equity structure: USOSM reports that more than 54% of the company is owned by the oral surgeons themselves.¹ Partner surgeons typically take a mix of cash and rolled equity when they affiliate, which aligns incentives toward long-term growth and helps recruit the next practice. That majority-surgeon ownership is unusual in private-equity-backed consolidation and is the feature USOSM leans on hardest with prospective partners — worth comparing to the doctor-partnership equity narrative at MB2 Dental.

USOSM does not publicly disclose revenue, and we are not publishing a third-party estimate. The only quantitative financial color in the public record is the size of its credit facilities and growth recognition (it has appeared on the Dallas Business Journal's regional fast-growth list and been recognized by Inc.), neither of which is a revenue figure.³ Any model should treat USOSM's top line as undisclosed. The company does point to operating metrics it can stand behind — a reported 100% partner-practice retention rate and partner-practice Net Promoter Scores of 80 or above, a level Bain & Company classifies as "world-class" — as evidence of surgeon retention.¹

Technology & Software Ecosystem

USOSM does not publicly name its core practice-management, imaging, or revenue-cycle software, so its technology posture has to be read from its service model rather than a vendor list. The company lists information technology as one of its centralized support functions, so platform-level IT, security, and systems coordination run from the Irving support center rather than office by office.¹

For an OMS-specific platform, the implied stack is heavier than a general dental office: surgical practices typically run advanced imaging such as cone-beam CT alongside billing systems that handle both medical and dental insurance codes, anesthesia records, and pre-authorization workflows. Centralizing IT across a multi-state network also implies investment in analytics and in the cybersecurity and HIPAA controls any handler of protected health information must maintain. These are reasonable inferences from the company's scale and stated functions, not a confirmed inventory.

Competitive Landscape

USOSM occupies a category that is largely its own. The biggest names in dental consolidation are general-dentistry-led platforms that treat specialties as an add-on — Heartland Dental (the scale leader at well over 1,800 offices), Aspen Dental (more than 1,100 offices), and others. None of those is a direct competitor for an oral surgeon weighing whether to affiliate; they compete for general-dentistry practices, while USOSM competes for OMS groups specifically.

The more apt comparisons are other specialty-focused consolidators. Specialized Dental Partners is a specialty-only DSO spanning endodontics, periodontics, and oral surgery, and Smile Doctors is the largest orthodontics-focused platform — both validate the same thesis USOSM embodies, that a single dental specialty can support a national roll-up. Against that field, USOSM's distinguishing claims are its first-mover status in OMS, its national reach across roughly 30 states, and its majority-surgeon ownership. Industry coverage also points to a small set of emerging OMS-focused platforms that could over time compete for the remaining pool of high-quality independent surgical groups — a normal dynamic as a fragmented specialty consolidates.

The structural tailwind behind all of these is the same: oral surgery remains a fragmented specialty of independent and small-group practices, many facing succession decisions, rising administrative complexity, and capital needs for imaging and surgical infrastructure that an MSO can absorb. USOSM's leadership has publicly described itself as "bullish" on the oral-surgery M&A environment, consistent with a market that is consolidating but far from consolidated.³

Market Position

USOSM reads as a mature, fast-growing platform optimized for depth in one specialty rather than breadth across dentistry. Its strengths are concrete: a first-mover position in OMS consolidation, national reach across roughly 30 states and more than 250 surgeons, a differentiated majority-surgeon cap table that aids recruiting and retention, a reported 100% partner-retention track record, and world-class NPS that suggests the partnership works for the clinicians inside it.

The pressures are the ones common to any private-equity-backed, M&A-driven platform. Growth has been financed with progressively larger credit facilities, so the model depends on cash flow keeping pace with leverage — a sensitivity that rises with interest rates. The acquisition engine faces a shrinking pool of large independent OMS groups as consolidation proceeds, which can push up multiples. And like all PPM/MSO structures, USOSM operates inside an evolving regulatory conversation about private equity's role in healthcare and the corporate-practice doctrines that govern these arrangements. None of these is unique to USOSM; together they frame the open questions for an investor — the platform's leverage and cash-flow profile (unknowable from public data given undisclosed revenue), how the new CEO paces M&A, and whether the surgeon-majority ownership holds through any eventual sponsor exit.

TMR Take: For operators (surgeons weighing affiliation): USOSM's pitch is specialty-specific support plus real equity — it serves only oral and maxillofacial surgeons, and reports that surgeons collectively own a majority of the company, rare among private-equity-backed consolidators. Diligence the management-fee structure, what "clinical autonomy" means in practice, and how the rolled equity converts in a future sponsor transition; the 100% retention and world-class NPS figures are company-reported and worth verifying with current partners. For vendors: USOSM buys at the platform level — IT and operations are run centrally from Irving, so the sell-in is one corporate evaluation rather than dozens of office-by-office decisions, but the buyer's needs are surgical (CBCT imaging, medical-and-dental billing, anesthesia documentation), not general-dentistry. The company doesn't disclose its stack, so how standardized systems already are across the network is the key qualifying question. For investors: USOSM is the first and largest oral-surgery-only MSO — roughly 30 states and 250-plus surgeons (company-reported) — controlled since a November 2021 recapitalization by Oak Hill Capital, with surgeons reported to own more than half the company. Note the ownership facts precisely: the current sponsor entered in 2021 (not 2018-2019), Thurston exited and RiverGlade sold control at that point, and deal terms were never disclosed. The watch items: an undisclosed top line (no company-confirmed revenue to model from), a leverage-funded acquisition strategy, and the July 2025 CEO transition from Rick Hall to Doug Drew.

Sources

1. U.S. Oral Surgery Management — company website and corporate press releases (footprint, surgeon ownership, retention, services, and technology functions).

2. Ownership and founding — RiverGlade Capital and Oak Hill Capital transaction announcements; Thurston Group exit announcement.

3. Industry coverage and growth reporting — Dentistry Today, DrBicuspid, Becker's Dental, and the Dallas Business Journal.

4. Leadership transition — U.S. Oral Surgery Management CEO announcement (Doug Drew named CEO; Richard Hall to Chairman).